Group 1 - The core point of the news is that MaiPu Medical has experienced a decline in stock price, falling 1.98% to 73.76 yuan per share, with a total market value of 4.946 billion yuan and a cumulative drop of 5.94% over the last four days [1] - MaiPu Medical, established on September 2, 2008, specializes in developing high-performance implantable medical devices using advanced manufacturing technology and synthetic materials [1] - The company's main revenue sources include artificial dura mater (45.42%), craniofacial repair and fixation systems (28.17%), absorbable regenerated oxidized cellulose and dura mater medical glue (24.39%), and other supplementary products (2.03%) [1] Group 2 - According to data, Bosera Fund has one fund heavily invested in MaiPu Medical, specifically the Bosera Health Growth Biweekly Redeemable Mixed A Fund, which holds 135,500 shares, accounting for 2.29% of the fund's net value [2] - The fund has incurred a floating loss of approximately 201,900 yuan today and a total floating loss of 631,400 yuan during the four-day decline [2] - The Bosera Health Growth Biweekly Redeemable Mixed A Fund was established on June 17, 2020, with a current scale of 358 million yuan and has achieved a year-to-date return of 14.58% [2]
迈普医学股价连续4天下跌累计跌幅5.94%，博时基金旗下1只基金持13.55万股，浮亏损失63.14万元